Nuvalent elects Grant Bogle as new independent Class I director

Nuvalent, Inc.

Grant Bogle elected to the Board effective Dec 5, 2024, as Class I director until 2025 annual meeting.
Initial equity grant: option for 4,851 shares at $93.73 (closing price) + RSU for 3,200 shares, both vesting over 3 years.
Bogle is independent per Nasdaq rules; will receive standard non-employee director cash and equity compensation.
Board also approved a new form of PSU award agreement for performance-vesting RSUs under the 2021 Stock Option and Incentive Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.